Fresenius SE Total Liabilities 2016-2024 | FSNUY

Fresenius SE total liabilities from 2016 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Fresenius SE total liabilities for the quarter ending June 30, 2024 were $25.749B, a 47.5% decline year-over-year.
  • Fresenius SE total liabilities for 2023 were $27.743B, a 40.42% decline from 2022.
  • Fresenius SE total liabilities for 2022 were $46.566B, a 7.77% decline from 2021.
  • Fresenius SE total liabilities for 2021 were $50.488B, a 8.8% increase from 2020.
Fresenius SE Annual Total Liabilities
(Millions of US $)
2023 $27,743
2022 $46,566
2021 $50,488
2020 $46,404
2019 $45,277
2018 $48,766
2017 $35,506
2016 $28,801
2015 $27,945
Fresenius SE Quarterly Total Liabilities
(Millions of US $)
2024-06-30 $25,749
2024-03-31 $26,238
2023-12-31 $27,743
2023-09-30 $49,028
2023-06-30 $49,049
2023-03-31 $47,637
2022-12-31 $46,566
2022-09-30 $46,504
2022-06-30 $46,909
2022-03-31 $47,727
2021-12-31 $50,488
2021-09-30 $50,582
2021-06-30 $51,225
2021-03-31 $49,975
2020-12-31 $46,404
2020-09-30 $49,238
2020-06-30 $46,579
2020-03-31 $46,352
2019-12-31 $45,277
2019-09-30 $44,550
2019-06-30 $44,451
2019-03-31 $44,472
2018-12-31 $48,766
2018-09-30 $47,563
2018-06-30 $48,421
2018-03-31 $48,698
2017-12-31 $35,506
2017-09-30 $37,527
2017-06-30 $35,062
2017-03-31 $34,632
2016-12-31 $28,801
2016-09-30 $27,653
2016-06-30 $28,650
2016-03-31 $26,958
2015-12-31 $27,945
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.838B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.658B 17.90
DaVita (DVA) United States $12.961B 16.76
Encompass Health (EHC) United States $10.241B 24.15
Chemed (CHE) United States $8.246B 25.34
Elanco Animal Health (ELAN) United States $6.367B 15.15
RadNet (RDNT) United States $5.842B 129.38
Option Care Health (OPCH) United States $3.955B 18.74
LifeStance Health (LFST) United States $2.843B 0.00
Amedisys (AMED) United States $2.803B 19.95
Astrana Health (ASTH) United States $2.251B 30.78
Addus HomeCare (ADUS) United States $2.189B 25.68
U.S Physical Therapy (USPH) United States $1.457B 38.29
Pennant (PNTG) United States $1.031B 41.68
Aveanna Healthcare Holdings (AVAH) United States $1.013B 0.00
Atai Life Sciences (ATAI) Germany $0.267B 0.00
Daxor (DXR) United States $0.042B 0.00
Psychemedics (PMD) United States $0.015B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00